Rapt Therapeutics, Inc.
(NASDAQ : RAPT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 4.50%75.010.0%$1241.75m
NVAXNovavax, Inc. 2.34%106.76102.0%$915.04m
VXRTVaxart, Inc. 33.25%16.150.0%$711.60m
AMGNAmgen, Inc. 0.64%251.631.3%$690.76m
REGNRegeneron Pharmaceuticals, Inc. 3.42%636.952.5%$652.12m
GILDGilead Sciences, Inc. 0.31%76.921.0%$627.79m
BIIBBiogen, Inc. 1.05%279.411.6%$599.04m
VRTXVertex Pharmaceuticals, Inc. 2.46%291.831.9%$472.00m
ILMNIllumina, Inc. 1.58%374.973.5%$301.23m
BNTXBioNTech SE 6.90%83.150.0%$220.56m
BMRNBioMarin Pharmaceutical, Inc. 0.70%125.274.3%$212.03m
ALXNAlexion Pharmaceuticals, Inc. 0.61%107.681.9%$206.07m
SGENSeattle Genetics, Inc. 2.45%172.716.1%$190.72m
SRNESorrento Therapeutics, Inc. 3.50%7.991.8%$188.67m
IMMUImmunomedics, Inc. 1.40%40.5311.0%$175.01m

Company Profile

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.